Inflammatory arthritis due to immune checkpoint inhibitors: challenges in diagnosis and treatment

Immunotherapy. 2017 Jan;9(1):5-8. doi: 10.2217/imt-2016-0117.

Authors

Laura C Cappelli¹, Jarushka Naidoo², Clifton O Bingham 3rd¹, Ami A Shah¹

Affiliations

¹ Division of Rheumatology, Department of Medicine, Johns Hopkins School of Medicine, 5200 Eastern Avenue, Baltimore MD, 21224, USA.
² Department of Oncology, Johns Hopkins School of Medicine,440 Eastern Avenue, Baltimore MD, 21224, USA.

PMID: 28000525
DOI: 10.2217/imt-2016-0117

No abstract available

Keywords: cancer; immune checkpoint inhibitors; immunotherapy; inflammatory arthritis.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Algorithms
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal / therapeutic use*
Arthritis / diagnosis*
Arthritis / drug therapy
Arthritis / etiology
Autoantibodies / metabolism
Autoimmune Hypophysitis / diagnosis*
Autoimmune Hypophysitis / drug therapy
Autoimmune Hypophysitis / etiology
Costimulatory and Inhibitory T-Cell Receptors / immunology
Humans
Immunotherapy / adverse effects
Immunotherapy / methods*
Infliximab / therapeutic use
Neoplasms / complications
Neoplasms / immunology
Neoplasms / therapy*

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal
Autoantibodies
Costimulatory and Inhibitory T-Cell Receptors
Infliximab

Grants and funding